MDCT angiography to evaluate the therapeutic effect of PTVE for esophageal varices

Table 3 Single- and multiple-factor analysis of relative factors of survival rate after modified percutaneous transhepatic variceal embolization

Variable	Univariate	Multivariate
	P value	Hazard ratio (95%CI)	P value
Gender (male vs female)	0.256	-	NS
Age, yr (≥ 53 vs < 53)	0.715	-	NS
Child-Pugh classification C vs (A + B)	0.015	1.827 (1.184-2.819)	0.006
Cause: Hepatitis B + hepatitis C vs alcoholic liver disease vs other	0.654	-	NS
Obliteration type	0.020	2.535 (1.779-3.613)	0.000
Variceal grade, severe	0.721	-	NS
Portal hypertensive gastropathy (yes vs no)	0.249	-	NS
Encephalopathy (yes vs no)	0.041	3.240 (0.725-6.874)	0.082
Ascites (yes vs no)	0.087	-	NS
Laboratory findings		-	NS
Leukocytes (× 109/L) (≥ 4.6 vs < 4.6)	0.759	-	NS
Hemoglobin (g/L) (< 83.7 vs≥ 83.7)	0.073	-	NS
Platelets (× 109/L) (< 94.9 vs≥ 94.9)	0.641	-	NS
ALT (U/L) (< 88.2 vs≥ 88.2)	0.528	-	NS
Albumin (g/L) (< 32.1 vs≥ 32.1)	0.193	-	NS
Bilirubin (µmol/L) (< 29.3 vs≥ 29.3)	0.282	-	NS
Prothrombin time (s) (≥ 16.4 vs < 16.4)	0.149	-	NS
Creatinine (μmol/L) (≥ 72.7 vs < 2.7)	0.591	-	NS

ALT: Alanine transaminase; NS: Not significant.